Making his first statement as Chancellor of the Exchequer today, Kwasi Kwarteng said the UK enjoys an “unbound entrepreneurial culture” and “immense global presence in sectors like… life sciences”, but that in many areas of the economy, he said, tax and regulation is holding back growth. Read more about key announcements for life sciences in the new Plan for Growth and three priority areas for expanding the supply side of the economy.
Yesterday the United Kingdom paid its final respects and laid to rest Queen Elizabeth II in an incredible state funeral in central London, a ceremony of which we haven’t seen in a generation and was marked and watched across the entire world. As the chapter closes on the 70 years of the Elizabethan age, I have reflected on the innovations and changes we have seen in the sector over that period and look forward to the advances the sector will make under our new King.
All of us at the BioIndustry Association (BIA) have been shocked and saddened by the death of the Queen. I shared a reflection on her life from a life science industry perspective on Friday. We are also posting official guidance from the UK Government on what to do during this extraordinary period for BIA members. Next Monday will see the State Funeral and a UK Bank Holiday – BIA will be closed on the day and next week’s Newscast will be on Tuesday. For the rest of this week, we continue to work as normal.
We spoke with Jelle Penders, CEO, CTO and Founder of SPARTA Biodiscovery, an Imperial College London spin-out commercialising the SPARTA® (Single Particle Automated Raman Trapping Analysis) technology.
Queen Elizabeth II was a stateswoman, not a scientist. But throughout her reign, she championed and embraced life science innovation. She made sure our society thought through and got comfortable with, the implications of what became scientifically possible.
In light of Zero Waste Week (5-9 September), we spoke to Amir Afshar, Co-Founder & Chief Product Officer, Shellworks about what businesses and individuals can do to become more environmentally sustainable. He believes that true sustainability doesn’t mean compromise and can be functional and cost-effective.
BIA will be striking a positive and optimistic tone for our sector this autumn to counter the doom and gloom newspaper headlines promote. Isn’t our sector amazing? BIA companies are turning incredible science into life-changing and planet-saving products and services with incredible vigour. This is what makes me incredibly optimistic for the future – where our ecosystem is central to the economic growth of the nation and the solutions to many of the challenges of our age. In this blog, I’ll focus on some of the priority areas for BIA work this autumn and my approach to them.
In light of Zero Waste Week, which is taking place 5-9 September, we spoke to Anna Hoesel, Life Sciences Development Lead, EQUANS about how the life sciences and biotech industry can use its strengths to champion sustainability and Net Zero, embracing energy, digital and industrial transitions and setting the tone for what best practice looks like for other sectors.
This year, BIA has partnered with Kidney Research UK, the largest charity dedicated to kidney research in the UK. From breaking the BIA Gala Dinner fundraising record and challenging BIA members to compete in the #850Challenge, to preparing to jump out of a plane come September, our 2022 Charity of the Year Partnership has been jam-packed, raising awareness and funds for #TeamKidney to tackle kidney disease. Read on to see what we’ve accomplished together over the last eight months and how we plan to continue supporting vital research and driving innovation to put kidney disease on the UK’s agenda.
UK companies are working across a diverse range of applications of engineering biology. Featured in the 'Power of Biology: The UK is engineering biology for global good' report, the following case study highlights Prokarium and gives additional insight into how this transformative technology can be used across healthcare, industry and agriculture.